We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BioAlliance Pharma to Continue its Phase III Clinical Trial with Livatag®

News   May 14, 2013

 
BioAlliance Pharma to Continue its Phase III Clinical Trial with Livatag®
 
 
Advertisement
 

RELATED ARTICLES

New Cancer Vaccine Ready for Human Trials

News

A new cancer vaccine, comprised of human antibodies fused with tumor-specific protein, is ready to begin human testing.

READ MORE

Controlled Human Infection Models for SARS-CoV-2 Vaccine Development

News

Infecting some volunteers with COVID-19 may provide valuable insights for future rounds of vaccine testing, but would require very strict controls, argues a group of infectious disease experts in the New England Journal of Medicine.

READ MORE

Trial of Saliva Test for COVID-19 Launched

News

Scientists from the Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly popped up a state-of-the-art COVID-19 testing laboratory in March, are now trialing a quicker way to obtain patient samples: through saliva.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE